Vivani Medical, Inc. (VANI)
USD 0.99
(-1.98%)
USD 0.99
(-1.98%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 26.96 Million USD | 26.95% |
| 2022 | 21.24 Million USD | 59.43% |
| 2021 | 13.32 Million USD | 44.14% |
| 2020 | 9.24 Million USD | -70.96% |
| 2019 | 31.82 Million USD | -13.6% |
| 2018 | 36.83 Million USD | 27.36% |
| 2017 | 28.92 Million USD | 3.86% |
| 2016 | 27.84 Million USD | 12.76% |
| 2015 | 24.69 Million USD | 17.19% |
| 2014 | 21.07 Million USD | 51.24% |
| 2013 | 13.93 Million USD | 7.25% |
| 2012 | 12.99 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 6.12 Million USD | 0.15% |
| 2024 Q2 | 5.58 Million USD | -7.29% |
| 2023 Q2 | 7 Million USD | 6.09% |
| 2023 Q3 | 7.14 Million USD | 2.01% |
| 2023 Q1 | 6.6 Million USD | -15.26% |
| 2023 FY | 26.6 Million USD | 25.27% |
| 2023 Q4 | 6.11 Million USD | -14.35% |
| 2022 Q3 | 5.44 Million USD | 33.2% |
| 2022 Q1 | 3.9 Million USD | 10.12% |
| 2022 FY | 21.24 Million USD | 59.43% |
| 2022 Q4 | 7.79 Million USD | 43.09% |
| 2022 Q2 | 4.08 Million USD | 4.61% |
| 2021 Q3 | 3.48 Million USD | 51.79% |
| 2021 Q4 | 3.54 Million USD | 1.81% |
| 2021 Q1 | 2.97 Million USD | 67.7% |
| 2021 FY | 13.32 Million USD | 44.14% |
| 2021 Q2 | 2.29 Million USD | -22.82% |
| 2020 Q1 | 7.52 Million USD | -10.85% |
| 2020 Q4 | 1.77 Million USD | 10.74% |
| 2020 Q3 | 1.6 Million USD | -29.37% |
| 2020 Q2 | 2.26 Million USD | -69.85% |
| 2020 FY | 9.24 Million USD | -70.96% |
| 2019 Q1 | 7.74 Million USD | -8.8% |
| 2019 FY | 31.82 Million USD | -13.6% |
| 2019 Q4 | 8.43 Million USD | 9.21% |
| 2019 Q3 | 7.72 Million USD | -2.4% |
| 2019 Q2 | 7.91 Million USD | 2.27% |
| 2018 Q3 | 9 Million USD | -0.56% |
| 2018 FY | 36.83 Million USD | 27.36% |
| 2018 Q1 | 10.07 Million USD | 16.09% |
| 2018 Q2 | 9.05 Million USD | -10.1% |
| 2018 Q4 | 8.48 Million USD | -5.77% |
| 2017 FY | 28.92 Million USD | 3.86% |
| 2017 Q1 | 7.43 Million USD | -4.53% |
| 2017 Q2 | 7.98 Million USD | 7.31% |
| 2017 Q3 | 7.35 Million USD | -7.81% |
| 2017 Q4 | 8.68 Million USD | 17.97% |
| 2016 Q1 | 5.96 Million USD | -3.33% |
| 2016 FY | 27.84 Million USD | 12.76% |
| 2016 Q4 | 7.79 Million USD | 10.28% |
| 2016 Q3 | 7.06 Million USD | 12.07% |
| 2016 Q2 | 6.3 Million USD | 5.72% |
| 2015 Q1 | 5.36 Million USD | -5.28% |
| 2015 FY | 24.69 Million USD | 17.19% |
| 2015 Q2 | 6.03 Million USD | 12.56% |
| 2015 Q4 | 6.16 Million USD | 0.58% |
| 2015 Q3 | 6.13 Million USD | 1.54% |
| 2014 Q4 | 5.66 Million USD | -3.04% |
| 2014 Q2 | 5.18 Million USD | 18.14% |
| 2014 Q1 | 4.38 Million USD | 31.4% |
| 2014 FY | 21.07 Million USD | 51.24% |
| 2014 Q3 | 5.84 Million USD | 12.75% |
| 2013 Q2 | 3.53 Million USD | 0.95% |
| 2013 FY | 13.93 Million USD | 7.25% |
| 2013 Q1 | 3.49 Million USD | 0.0% |
| 2013 Q4 | 3.33 Million USD | -6.38% |
| 2013 Q3 | 3.56 Million USD | 0.95% |
| 2012 FY | 12.99 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -140.244% |
| Cerus Corporation | 143.15 Million USD | 81.164% |
| OrthoPediatrics Corp. | 137.01 Million USD | 80.32% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -137.35% |
| Talis Biomedical Corporation | 67.18 Million USD | 59.865% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -8.093% |
| Inogen, Inc. | 236.08 Million USD | 88.578% |
| Spectral AI, Inc. | 20.86 Million USD | -29.242% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 51.846% |
| CVRx, Inc. | 76.14 Million USD | 64.586% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -664.315% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -115.91% |
| Orthofix Medical Inc. | 667.42 Million USD | 95.96% |
| Venus Concept Inc. | 80.47 Million USD | 66.493% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 52.34% |
| Bioventus Inc. | 409.91 Million USD | 93.422% |
| BrainsWay Ltd. | 28.01 Million USD | 3.758% |
| Envoy Medical, Inc. | 17.89 Million USD | -50.659% |
| electroCore, Inc. | 32.03 Million USD | 15.816% |
| IceCure Medical Ltd | 16.87 Million USD | -59.783% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 36.451% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -52.923% |
| MaxCyte, Inc. | 84.84 Million USD | 68.219% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -117.254% |
| Nexalin Technology, Inc. | 5.78 Million USD | -366.413% |
| PAVmed Inc | 64.82 Million USD | 58.405% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 47.208% |
| RxSight, Inc. | 103.85 Million USD | 74.035% |
| Sight Sciences, Inc. | 126.44 Million USD | 78.675% |
| SI-BONE, Inc. | 156.35 Million USD | 82.754% |
| TELA Bio, Inc. | 84.18 Million USD | 67.97% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 61.509% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 86.741% |
| LivaNova PLC | 843.54 Million USD | 96.803% |
| 908 Devices Inc. | 68.08 Million USD | 60.392% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 94.424% |
| Nemaura Medical Inc. | 7.13 Million USD | -277.724% |
| NeuroPace, Inc. | 75.29 Million USD | 64.188% |
| LENSAR, Inc. | 33.33 Million USD | 19.111% |
| Apyx Medical Corporation | 51.01 Million USD | 47.146% |
| Cutera, Inc. | 197.72 Million USD | 86.362% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -8.813% |
| BioSig Technologies, Inc. | 28.53 Million USD | 5.485% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 85.917% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 25.222% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 96.776% |
| Axonics, Inc. | 270.2 Million USD | 90.02% |
| Outset Medical, Inc. | 198.77 Million USD | 86.434% |
| IRIDEX Corporation | 31.81 Million USD | 15.242% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 85.038% |
| IRadimed Corporation | 30.12 Million USD | 10.483% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -216.045% |
| INVO Bioscience, Inc. | 7.85 Million USD | -243.359% |
| Telesis Bio, Inc. | 63.48 Million USD | 57.528% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 72.611% |
| Varex Imaging Corporation | 224.8 Million USD | 88.005% |
| Quipt Home Medical Corp. | 148.66 Million USD | 81.862% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -130.018% |
| Pulmonx Corporation | 112.68 Million USD | 76.071% |
| Dynatronics Corporation | 9.9 Million USD | -172.153% |
| Modular Medical, Inc. | 17.52 Million USD | -53.831% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -33.576% |
| Semler Scientific, Inc. | 38.94 Million USD | 30.76% |
| InMode Ltd. | 215.68 Million USD | 87.498% |
| Bruker Corporation | 1.07 Billion USD | 97.495% |
| Cytosorbents Corporation | 48.33 Million USD | 44.214% |
| DexCom, Inc. | 1.69 Billion USD | 98.406% |
| Align Technology, Inc. | 2.07 Billion USD | 98.702% |
| Viveve Medical, Inc. | 22.17 Million USD | -21.612% |
| ZimVie Inc. | 275.12 Million USD | 90.199% |
| Movano Inc. | 29.69 Million USD | 9.178% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 80.356% |
| Nexalin Technology, Inc. | 5.78 Million USD | -366.413% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -664.315% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 95.513% |
| Profound Medical Corp. | 33.6 Million USD | 19.755% |
| Insulet Corporation | 939.9 Million USD | 97.131% |
| enVVeno Medical Corporation | 25.23 Million USD | -6.843% |
| Surmodics, Inc. | 98.69 Million USD | 72.679% |
| iCAD, Inc. | 22.22 Million USD | -21.327% |
| Nuwellis, Inc. | 22.61 Million USD | -19.246% |
| Biotricity, Inc. | 17.18 Million USD | -56.914% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 93.953% |
| Aethlon Medical, Inc. | 12.27 Million USD | -119.629% |
| InspireMD, Inc. | 22.95 Million USD | -17.495% |
| PAVmed Inc. | 64.82 Million USD | 58.405% |
| BIOLASE, Inc. | 34.66 Million USD | 22.204% |
| Beyond Air, Inc. | 61.7 Million USD | 56.297% |
| FONAR Corporation | 28.6 Million USD | 5.732% |
| AxoGen, Inc. | 149.33 Million USD | 81.943% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 84.773% |
| Inari Medical, Inc. | 448.59 Million USD | 93.989% |
| UFP Technologies, Inc. | 58.08 Million USD | 53.58% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -447.224% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -326.777% |
| Tenon Medical, Inc. | 16.96 Million USD | -58.917% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -264.737% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 38.859% |
| AdaptHealth Corp. | 1.07 Billion USD | 97.499% |
| Sintx Technologies, Inc. | 15.2 Million USD | -77.39% |
| NanoVibronix, Inc. | 4.97 Million USD | -442.228% |
| Quanterix Corporation | 118.1 Million USD | 77.168% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -130.018% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -86.712% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 93.133% |
| TransMedics Group, Inc. | 182.82 Million USD | 85.251% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 3.919% |
| NeuroMetrix, Inc. | 11.09 Million USD | -142.951% |
| Hyperfine, Inc. | 52.87 Million USD | 48.999% |
| Establishment Labs Holdings Inc. | 172 Million USD | 84.323% |
| Biomerica, Inc. | 6.97 Million USD | -286.429% |
| Bone Biologics Corporation | 9.42 Million USD | -186.001% |
| AVITA Medical, Inc. | 80.77 Million USD | 66.619% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -161.511% |
| Silk Road Medical, Inc | 186.35 Million USD | 85.53% |